Alcohol gel treatment for aggressive angiomas
Part of Bones, joints & muscles, Cancer clinical trials.
This trial studies a treatment using a special gelled alcohol to shrink aggressive angiomas (abnormal blood vessel growths). It aims to see if the procedure is safe, feasible, and works well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an aggressive angioma (a type of blood vessel growth) that needs treatment.
- You are scheduled to receive or have received gelled alcohol sclerotherapy at the University Hospital of Saint-Etienne.
- You have not had this type of treatment elsewhere before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a treatment for people with aggressive spinal hemangiomas—blood vessel growths in the spine that cause pain, weakness, or other symptoms. You may benefit if your hemangioma is causing problems and has been confirmed by imaging tests.
This trial tests a topical gel (a cream you apply to skin) containing sirolimus to treat angiokeratomas, which are small growths on the skin. The goal is to see if this treatment is safe and effective.
This trial tests a liquid embolic agent (a gel-like material) injected into the blood vessels of a brain arteriovenous malformation (AVM) to block abnormal blood flow. It’s for people aged 18 to 80 with certain types of AVMs that doctors think can be treated this way.
This trial tests a special gel designed to prevent raised, thick scars (hypertrophic scars) after surgery or injury. If you have a new scar from a C-section, breast implant, or clean cut, this study may help reduce scarring.
This trial tests if a less invasive ultrasound-guided ethanol injection works as well as laparoscopic surgery for treating ovarian endometriomas (fluid-filled cysts from endometriosis). It may offer a treatment option with fewer side effects.
This trial tests an oral medication (ABSK043) that may help your immune system fight certain rare sarcomas. It is for people with intimal sarcoma, head and neck angiosarcoma, or epithelioid hemangioendothelioma that has spread or cannot be removed by surgery.
Hear when a new Bone Angioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.